This article has Open Peer Review reports available.
Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population
- Stefano Rusconi†1, 4Email author,
- Vania Giacomet†2,
- Chiara Mameli†2,
- Alessandra Viganò2,
- Ottavia Viganò1,
- Fulvio Adorni3,
- Massimo Galli1 and
- Gian Vincenzo Zuccotti2
© Rusconi et al.; licensee BioMed Central Ltd. 2012
Received: 21 November 2011
Accepted: 23 July 2012
Published: 6 August 2012
Open Peer Review reports
Pre-publication versions of this article are available by contacting email@example.com.
|21 Nov 2011||Submitted||Original manuscript|
|5 May 2012||Reviewed||Reviewer Report - Raffaele Badolato|
|14 May 2012||Reviewed||Reviewer Report - Pope Kosalaraksa|
|6 Jun 2012||Author responded||Author comments - Stefano Rusconi|
|Resubmission - Version 2|
|6 Jun 2012||Submitted||Manuscript version 2|
|12 Jul 2012||Author responded||Author comments - Stefano Rusconi|
|Resubmission - Version 3|
|12 Jul 2012||Submitted||Manuscript version 3|
|23 Jul 2012||Editorially accepted|
|6 Aug 2012||Article published||10.1186/1471-2334-12-179|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.